Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
The first commercial passenger flight between the USA and Cuba in more than 55 years has landed as relations continue to improve.
David Luiz has returned to former club Chelsea from PSG for a fee believed to be £30m
A fine start into a new month with sunny spells and cloud coming and going.